[Depressive pseudodementia: clinico-therapeutical implications].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J M Barjau Romero.
Explore the source record for details and available documents.
The aim of this study was to provide an update of the epidemiology of eating disorders (anorexia nervosa and bulimia nervosa), focusing on incidence and prevalence as well as other factors as age and sex. We made a review of the existing literature in the matter in the last decades. Likewise, we made an extent evaluation of the hypothetical pathogenic impact that exerts mass media (television and printed mass media) in these pathologies. We found an evident increase in incidence as well as prevalence of these disorders though it's far from being considered epidemic. We also found an undeniable influence of mass media in the genesis and maintenance of these disorders. However, mass media would exert a positive influence in the popularization of these entities to the general population that would result in a higher demand in general practice.
In the limits between dementia and depression we find a clinical entity in permanent controversy; Depressive Pseudodementia. Depressive pseudodementia is defended by some authors and criticised by others and set us in the diagnostic frontier palced between the cognitive and the affective, between neurology and psychiatry. The entity is not well delimited and reaches diagnostic relevance clinical, evolution and response aspects. In the present issue, we realize a reflection on the term depressive pseudodementia with a review of the scientific literature with special attention in clinical and diagnostic subjets. We conclude that depressive pseudodementia although considering diagnostic limitations is still a valid term in clinical practice, and it eases the approximation, diagnosis and treatment of patients with mixed symptoms of cognitive and depressive type.
Since 1992 it has been reported that obsessive-compulsive behavior may emerge in patients treated with clozapine. We would like to report a case of obsessive-compulsive behavior emerging after initiation of treatment with clozapine in a 22-year-old man with a diagnosis of schizoaffective disorder that was successfully treated with fluoxetine.